Our results showed that the expression of IL-17A target genes OCLN and IL-22 decreased in the colorectum of ArgmyeKO mice during colitis, which likely contributed to disruption of the intestinal barrier integrity thereby aggravating colitis. The gene discussed is IL17A; the disease is colitis.